Hjem › Plasmacellekræft › Florida
Plasmacellekræft kliniske forsøg i Florida
4 studier for Plasmacellekræft søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center, Coral Gables
- University of Miami Hospital and Clinics - Deerfield Beach, Deerfield Beach
- Sylvester Comprehensive Cancer Center- Doral, Doral
- og 12 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT06152575A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Mayo Clinic Hospital - Florida, Jacksonville
- University of Miami Don Soffer Clinical Research Center, Miami
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT05651932Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Sylvester Comprehensive Cancer Center, Miami
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 20. feb. 2026 · NCT05745285Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
- Moffitt Cancer Center, Tampa
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. dec. 2025 · NCT06947083Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.